FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment …
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment …
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment …
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment …
For years, medical experts have defined obesity primarily based on body mass index, which measures stored fat by calculating height and weight, to determine a …
Most adults in the United States drink alcohol, but there is steadily growing public concern about the health effects of moderate drinking. The latest science …
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment …
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment …
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, …
“Ooh, that’s a big one,” Donald Trump said Monday as he signed an executive order – one of dozens during his first hours as president …
Amid a deluge of executive actions, the Trump administration has asked federal health agencies to pause external communications, such as regular scientific reports, updates to …